Can a patient with a ceftriaxone (Ceftriaxone) allergy receive cefazolin (Cefazolin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can a Patient with Ceftriaxone Allergy Receive Cefazolin?

Yes, cefazolin can generally be safely administered to patients with ceftriaxone allergy because these two cephalosporins have distinct side chain structures that do not cross-react. 1

Understanding the Mechanism of Cross-Reactivity

The key principle is that cross-reactivity between cephalosporins depends primarily on similarity of R1 side chains, not the shared beta-lactam ring. 1

  • Cefazolin has a unique side chain structure that differs from ceftriaxone and appears to have very low cross-reactivity with other beta-lactams. 1
  • Ceftriaxone has its own distinct R2 side chain that can serve as the allergic determinant independent of the beta-lactam ring. 2
  • A documented case report demonstrates that a patient who tolerated cefazolin subsequently experienced anaphylaxis to ceftriaxone, confirming that tolerance to one does not predict tolerance to the other when side chains differ. 2

Clinical Evidence Supporting Safety

  • Multiple studies confirm that cephalosporins with dissimilar side chains can be safely used in patients allergic to other cephalosporins. 3
  • In one study, 41 penicillin-allergic patients tolerated cefazolin, cefuroxime, and ceftriaxone when these agents had different side chains from the offending penicillin. 3
  • The cross-reactivity rate between cephalosporins with dissimilar side chains is negligible. 4, 5

Important Caveats and Exceptions

However, there is one critical exception to consider: If the patient had a severe reaction suggesting sensitivity to the beta-lactam ring itself (rather than the side chain), they could theoretically react to any beta-lactam antibiotic. 1

  • The 2022 guidelines describe a rare outlier patient who was skin test-positive to all beta-lactam reagents tested, including cefazolin, ceftibuten, carbapenems, and aztreonam, indicating sensitivity to the beta-lactam ring itself. 1
  • This represents an extremely uncommon scenario but should be considered in patients with multiple documented beta-lactam allergies. 1

Practical Approach

For most patients with ceftriaxone allergy:

  • Cefazolin can be administered without additional precautions if the ceftriaxone allergy is well-documented and isolated. 3
  • Skin testing is generally not required unless the patient has multiple documented cephalosporin allergies. 1

For patients with severe ceftriaxone reactions (anaphylaxis) or multiple cephalosporin allergies:

  • Consider skin testing with cefazolin before administration to rule out the rare possibility of beta-lactam ring sensitivity. 1
  • Administer the first dose in a monitored setting if there is any uncertainty. 2

Common Pitfall to Avoid

Do not assume that tolerance to cefazolin predicts tolerance to ceftriaxone (or vice versa). 2 The case report clearly demonstrates that these are immunologically distinct allergens, and cross-tolerance cannot be assumed based on tolerance to one agent. 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lack of allergic cross-reactivity to cephalosporins among patients allergic to penicillins.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2001

Research

Use of selected cephalosporins in penicillin-allergic patients: a paradigm shift.

Diagnostic microbiology and infectious disease, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.